Department of Psychiatry, Singapore General Hospital, Singapore.
Ann Acad Med Singap. 2009 Nov;38(11):974-9.
There is a high prevalence of chronic pain disorders in the population and the individual and societal costs are large. Antidepressants have been used in the treatment of chronic pain and the pain-relieving effects are independent of the mood-elevating properties. We reviewed randomised-controlled trials, systematic reviews and meta-analyses of antidepressants in the treatment of chronic pain disorders which were identified through searches of MEDLINE and EMBASE. Antidepressants have proved to be effective in the treatment of fibromyalgia, chronic low back pain, diabetic neuropathy, postherpetic neuralgia and chronic headache, in particular tricyclic antidepressants (TCAs). There is emerging evidence that newer dual-action antidepressants are equally efficacious. Antidepressants provide a viable option in the management of chronic pain disorders. Further research into novel antidepressants will aid the pain clinician in optimising treatment for patients.
人群中慢性疼痛障碍的患病率很高,个人和社会的成本也很大。抗抑郁药已被用于治疗慢性疼痛,其止痛效果与改善情绪的作用无关。我们通过对 MEDLINE 和 EMBASE 的检索,对治疗慢性疼痛障碍的抗抑郁药的随机对照试验、系统评价和荟萃分析进行了综述。抗抑郁药已被证明在治疗纤维肌痛、慢性腰痛、糖尿病性神经病变、带状疱疹后神经痛和慢性头痛方面有效,尤其是三环类抗抑郁药(TCAs)。有新的证据表明,新型的双重作用抗抑郁药同样有效。抗抑郁药为慢性疼痛障碍的治疗提供了可行的选择。对新型抗抑郁药的进一步研究将有助于疼痛临床医生为患者优化治疗。